Sumitomo Mitsui DS Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.8M | Buy |
30,587
+81
| +0.3% | +$30K | 0.08% | 186 |
|
|
2026
Q1 | $8.93M | Sell |
30,506
-2,018
| -6% | -$663K | 0.07% | 222 |
|
|
2025
Q4 | $11.4M | Buy |
32,524
+233
| +0.7% | +$78.7K | 0.09% | 178 |
|
|
2025
Q3 | $10.4M | Buy |
32,291
+235
| +0.7% | +$73.1K | 0.08% | 190 |
|
|
2025
Q2 | $12.5M | Buy |
32,056
+2,001
| +7% | +$805K | 0.11% | 160 |
|
|
2025
Q1 | $13.1M | Buy |
30,055
+476
| +2% | +$191K | 0.13% | 141 |
|
|
2024
Q4 | $10.9M | Buy |
29,579
+1,569
| +6% | +$657K | 0.11% | 149 |
|
|
2024
Q3 | $14.6M | Buy |
28,010
+1,175
| +4% | +$628K | 0.16% | 117 |
|
|
2024
Q2 | $14.5M | Buy |
26,835
+1,458
| +6% | +$771K | 0.17% | 107 |
|
|
2024
Q1 | $13.2M | Buy |
25,377
+773
| +3% | +$384K | 0.16% | 114 |
|
|
2023
Q4 | $11.6M | Buy |
24,604
+815
| +3% | +$377K | 0.15% | 146 |
|
|
2023
Q3 | $10.4M | Buy |
23,789
+1,042
| +5% | +$473K | 0.16% | 120 |
|
|
2023
Q2 | $10.1M | Buy |
22,747
+2,883
| +15% | +$1.33M | 0.15% | 125 |
|
|
2023
Q1 | $9.13M | Buy |
19,864
+850
| +4% | +$405K | 0.16% | 111 |
|
|
2022
Q4 | $9.75M | Buy |
19,014
+1,027
| +6% | +$521K | 0.2% | 98 |
|
|
2022
Q3 | $8.17M | Buy |
17,987
+1,360
| +8% | +$651K | 0.19% | 101 |
|
|
2022
Q2 | $8.02M | Buy |
16,627
+846
| +5% | +$419K | 0.19% | 99 |
|
|
2022
Q1 | $7.75M | Buy |
15,781
+31
| +0.2% | +$14.2K | 0.16% | 113 |
|
|
2021
Q4 | $7.3M | Buy |
15,750
+535
| +4% | +$225K | 0.15% | 128 |
|
|
2021
Q3 | $5.67M | Sell |
15,215
-117
| -0.8% | -$44.5K | 0.13% | 144 |
|
|
2021
Q2 | $5.85M | Sell |
15,332
-744
| -5% | -$284K | 0.14% | 145 |
|
|
2021
Q1 | $5.77M | Sell |
16,076
-11
| -0.1% | -$3.54K | 0.15% | 137 |
|
|
2020
Q4 | $5.17M | Buy |
16,087
+347
| +2% | +$106K | 0.15% | 137 |
|
|
2020
Q3 | $4.23M | Sell |
15,740
-4,412
| -22% | -$1.19M | 0.13% | 142 |
|
|
2020
Q2 | $5.3M | Sell |
20,152
-1,007
| -5% | -$269K | 0.18% | 107 |
|
|
2020
Q1 | $4.8M | Buy |
21,159
+460
| +2% | +$125K | 0.2% | 103 |
|
|
2019
Q4 | $6.25M | Sell |
20,699
-596
| -3% | -$164K | 0.21% | 100 |
|
|
2019
Q3 | $5.11M | Buy |
21,295
+1,083
| +5% | +$297K | 0.19% | 115 |
|
|
2019
Q2 | $5.7M | Sell |
20,212
-85,007
| -81% | -$23.2M | 0.23% | 92 |
|
|
2019
Q1 | $30.2M | Sell |
105,219
-127,617
| -55% | -$36.9M | 0.5% | 54 |
|
|
2018
Q4 | $61.1M | Buy |
232,836
+68,725
| +42% | +$18.9M | 1.11% | 22 |
|
|
2018
Q3 | $45M | Sell |
164,111
-32,386
| -16% | -$8.41M | 0.69% | 40 |
|
|
2018
Q2 | $46.8M | Sell |
196,497
-90,044
| -31% | -$20.9M | 0.72% | 35 |
|
|
2018
Q1 | $63M | Buy |
286,541
+171,432
| +149% | +$40.3M | 0.93% | 27 |
|
|
2017
Q4 | $25.9M | Buy |
115,109
+94,748
| +465% | +$20.2M | 0.39% | 68 |
|
|
2017
Q3 | $3.87M | Sell |
20,361
-387
| -2% | -$73.7K | 0.06% | 236 |
|
|
2017
Q2 | $3.9M | Sell |
20,748
-1,153
| -5% | -$207K | 0.06% | 243 |
|
|
2017
Q1 | $3.62M | Buy |
21,901
+1,834
| +9% | +$292K | 0.06% | 252 |
|
|
2016
Q4 | $2.88M | Sell |
20,067
-192
| -0.9% | -$25.7K | 0.06% | 263 |
|
|
2016
Q3 | $2.54M | Buy |
20,259
+318
| +2% | +$41.1K | 0.06% | 277 |
|
|
2016
Q2 | $2.62M | Buy |
19,941
+276
| +1% | +$37.8K | 0.08% | 219 |
|
|
2016
Q1 | $2.73M | Buy |
19,665
+762
| +4% | +$102K | 0.08% | 210 |
|
|
2015
Q4 | $2.63M | Sell |
18,903
-988
| -5% | -$136K | 0.09% | 212 |
|
|
2015
Q3 | $2.78M | Sell |
19,891
-410
| -2% | -$61.6K | 0.1% | 206 |
|
|
2015
Q2 | $3.33M | Sell |
20,301
-1,325
| -6% | -$212K | 0.11% | 204 |
|
|
2015
Q1 | $3.34M | Sell |
21,626
-1,875
| -8% | -$267K | 0.1% | 200 |
|
|
2014
Q4 | $2.95M | Sell |
23,501
-2,321
| -9% | -$287K | 0.09% | 218 |
|
|
2014
Q3 | $3.09M | Sell |
25,822
-2,652
| -9% | -$304K | 0.09% | 215 |
|
|
2014
Q2 | $3.06M | Sell |
28,474
-2,734
| -9% | -$282K | 0.09% | 234 |
|
|
2014
Q1 | $3.11M | Sell |
31,208
-2,072
| -6% | -$187K | 0.09% | 212 |
|
|
2013
Q4 | $3.07M | Sell |
33,280
-3,400
| -9% | -$302K | 0.09% | 211 |
|
|
2013
Q3 | $3.07M | Sell |
36,680
-2,462
| -6% | -$211K | 0.09% | 204 |
|
|
2013
Q2 | $3.2M | Buy |
+39,142
| New | +$2.93M | 0.09% | 202 |
|
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
Sumitomo Mitsui DS Asset Management's ELV Position: Q2 2026 in Review
Sumitomo Mitsui DS Asset Management increased its Elevance Health (ELV) stake by 0.27% in Q2 2026, buying an estimated $30K and bringing the position to 30,587 shares worth $11.8M. The position accounts for 0.08% of the portfolio, ranked #186.
Sumitomo Mitsui DS Asset Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $63M in Q1 2018. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Sumitomo Mitsui DS Asset Management held 30,587 shares of Elevance Health worth $11.8M as of Q2 2026.
- Sumitomo Mitsui DS Asset Management bought 81 Elevance Health shares in Q2 2026, an estimated $30K.
- Elevance Health made up 0.08% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #186 holding.
- Sumitomo Mitsui DS Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Sumitomo Mitsui DS Asset Management's Elevance Health position peaked at $63M in Q1 2018.
- 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.